Onyx Bridge Wealth Group LLC Astrazeneca PLC Transaction History

Onyx Bridge Wealth Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 10, 2023	BUY	$63.15 - $71.6 $7,199 - $8,162	114 Added 3.47%	3,399 $235,000
Q4 2022 Jan 11, 2023	BUY	$54.21 - $70.44 $178,079 - $231,395	3,285 New	3,285 $0
Q2 2022 Jul 25, 2022	BUY	$59.26 - $71.14 $4,385 - $5,264	74 Added 2.27%	3,328 $217,000
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $23,346 - $28,123	-419 Reduced 11.41%	3,254 $215,000
Q4 2021 Jan 18, 2022	SELL	$54.02 - $63.83 $21,445 - $25,340	-397 Reduced 9.75%	3,673 $214,000
Q3 2021 Oct 20, 2021	BUY	$55.56 - $60.79 $226,129 - $247,415	4,070 New	4,070 $241,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Onyx Bridge Wealth Group LLC, based on Form 13F filings with the SEC.

Stay updated on Onyx Bridge Wealth Group LLC with notifications on news.